Fertility considerations in the management of gynecologic malignancies (Q34143263)

31 July 2017

Fertility considerations in the management of gynecologic malignancies (English)

1 reference

31 July 2017

5

Nadeem R Abu-Rustum

1 reference

31 July 2017

1

Nicole Noyes

1 reference

31 July 2017

Jaime M Knopman

2

1 reference

31 July 2017

Kara Long

series ordinal

3

1 reference

31 July 2017

Jaclyn M Coletta

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

13 October 2010

1 reference

31 July 2017

1 reference

31 July 2017

120

1 reference

31 July 2017

3

1 reference

31 July 2017

326-333

1 reference

Reproductive concerns of women treated with radical trachelectomy for cervical cancer

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Human ovarian reserve from conception to the menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Statistical contributions to the study of human fertility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Factors useful in predicting the success of oocyte donation: a 3-year retrospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Reproductive outcome in patients with diminished ovarian reserve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

The variability of female reproductive ageing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Do cycle disturbances explain the age-related decline of female fertility? Cycle characteristics of women aged over 40 years compared with a reference population of young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Effects of age on hormonal and ultrasound markers of ovarian reserve in Chinese women with proven fertility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Follicular vascularity--the predictive value of transvaginal power Doppler ultrasonography in an in-vitro fertilization programme: a preliminary study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Risk of menopause during the first year after breast cancer diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Surviving childhood and reproductive-age malignancy: effects on fertility and future parenthood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Kidney disease is an independent risk factor for adverse fetal and maternal outcomes in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Radiation damage to the uterus -- review of the effects of treatment of childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Factors affecting late mortality from heart disease after treatment of Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Late cardiotoxicity after treatment for Hodgkin lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Rates of postcancer parenthood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Genetic disease in offspring of long-term survivors of childhood and adolescent cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Sex ratio among offspring of childhood cancer survivors treated with radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Genetic effects of radiotherapy for childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Pregnancy after human oocyte cryopreservation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Clinical evaluation of the efficiency of an oocyte donation program using egg cryo-banking.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Oocyte cryopreservation outcomes including pre-cryopreservation and post-thaw meiotic spindle evaluation following slow cooling and vitrification of human oocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

ASRM Practice Committee response to Rybak and Lieman: elective self-donation of oocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Effect of total abdominal hysterectomy on ovarian blood supply in women of reproductive age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

Post-treatment parenthood in Hodgkin's lymphoma survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.012

10.1016/J.YGYNO.2010.09.012

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference